Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells - Wikidata - wikimedia - TriplyDB

Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells

Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells

http://www.wikidata.org/entity/Q28369657

about

Sensitivity to a nonpeptidic compound (RPR103611) blocking human immunodeficiency virus type 1 Env-mediated fusion depends on sequence and accessibility of the gp41 loop region Role of human immunodeficiency virus (HIV) type 1 envelope in the anti-HIV activity of the betulinic acid derivative IC9564 Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor Resistance to a drug blocking human immunodeficiency virus type 1 entry (RPR103611) is conferred by mutations in gp41 Characterization of a novel type of HIV-1 particle assembly inhibitor using a quantitative luciferase-Vpr packaging-based assay Synthesis of antitumor-active betulinic acid-derived hydroxypropargylamines by copper-catalyzend mannich reactions.Synthesis, encapsulation and antitumor activity of new betulin derivatives.Discovery, synthesis, and biological evaluation of a novel group of selective inhibitors of filoviral entry Betulinic acid suppresses constitutive and TNFalpha-induced NF-kappaB activation and induces apoptosis in human prostate carcinoma PC-3 cells.Novel compounds in preclinical/early clinical development for the treatment of HIV infections.A low-molecular-weight entry inhibitor of both CCR5- and CXCR4-tropic strains of human immunodeficiency virus type 1 targets a novel site on gp41 Biotransformation of the antimelanoma agent betulinic acid by Bacillus megaterium ATCC 13368.Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection.Ionic derivatives of betulinic acid as novel HIV-1 protease inhibitors.A small-molecule antagonist of virion assembly.HIV entry inhibitors and their potential in HIV therapy New anti-HIV agents and targets.Antiviral therapy for human immunodeficiency virus infections Bifunctional anti-human immunodeficiency virus type 1 small molecules with two novel mechanisms of action.Ionic derivatives of betulinic acid exhibit antiviral activity against herpes simplex virus type-2 (HSV-2), but not HIV-1 reverse transcriptase The discovery of a class of novel HIV-1 maturation inhibitors and their potential in the therapy of HIV.A mimic of HIV-1 nucleocapsid protein impairs reverse transcription and displays antiviral activity.New betulinic acid derivatives for bevirimat-resistant human immunodeficiency virus type-1.Plant-derived triterpenoids and analogues as antitumor and anti-HIV agents Anti-AIDS agents. 78. Design, synthesis, metabolic stability assessment, and antiviral evaluation of novel betulinic acid derivatives as potent anti-human immunodeficiency virus (HIV) agents Proteasome regulators: activators and inhibitors.HIV microbicides: state-of-the-art and new perspectives on the development of entry inhibitors.Amphipathic properties of HIV-1 gp41 fusion inhibitors.Escape from human immunodeficiency virus type 1 (HIV-1) entry inhibitors.Betulinic Acid: Recent Advances in Chemical Modifications, Effective Delivery, and Molecular Mechanisms of a Promising Anticancer Therapy.Hyaluronidase Inhibitory Activity of Pentacylic Triterpenoids from Prismatomeris tetrandra (Roxb.) K. Schum: Isolation, Synthesis and QSAR Study.Activation and inhibition of the proteasome by betulinic acid and its derivatives.Role of the ectodomain of the gp41 transmembrane envelope protein of human immunodeficiency virus type 1 in late steps of the membrane fusion process.Oxysterols, but not cholesterol, inhibit human immunodeficiency virus replication in vitro.Tri-N-Boc-tetraazamacrocycle-nucleoside conjugates: synthesis and anti-HIV activities.An amphiphilic conjugate approach toward the design and synthesis of betulinic acid-polyphenol conjugates as inhibitors of the HIV-1 gp41 fusion core formation.Production of a highly potent epoxide through the microbial metabolism of 3β-acetoxyurs-11-en-13β,28-olide by Aspergillus niger culture.A new single-stage method for obtaining of betulin phenylcarbamates.Safety evaluation of a new anxiolytic product containing botanicals Souroubea spp. and Platanus spp. in dogs.Poly(lactic-co-glycolic acid)-loaded nanoparticles of betulinic acid for improved treatment of hepatic cancer: characterization, in vitro and in vivo evaluations.

P2860

Q28343901-D6BEF1C1-AA55-4BE6-921F-55953C421EAD Q28345233-3A5CB173-4A62-4806-9096-601679E0C399 Q28379084-27F49BFE-1AA2-4C23-B47A-2AD9040683FB Q28379194-5F88EA56-F298-4B60-9109-6F501734C351 Q28477791-BB6A980C-12EA-47D5-B675-D7FB1FEEF3DE Q30317883-6372718D-130A-478A-9632-1B96FF64A31C Q30318499-EC64A2CF-7C5C-4FBA-918D-ECD437A3D872 Q33785133-8C8FA4C9-B7ED-47BC-A78D-15D3FD6FBFE4 Q33830333-73F8F519-DF47-4085-8484-26C8D8F223F6 Q33966254-49F890A7-353D-448B-88C5-DC4BFC401A70 Q33966639-4EF71CAC-2C05-4BB8-BD47-AFB306D7D0DA Q33987607-280D8DB9-31ED-4A80-8C86-B1B42BAF1670 Q33996826-1216E972-7EC0-460E-B1B3-ED38ABF29154 Q34045239-2E2267D8-5357-4226-83D7-1FA1F9FDFB10 Q34489215-C7D0F8FE-25E3-4D01-909C-18043D84D0D2 Q34595921-951437CD-CFFD-43F5-8568-09802A8FA77D Q34944447-DEE1671C-C563-4644-97AE-607F56D669B3 Q35366050-6B4A7BCB-BA76-4F73-8080-B53DE0D675FA Q35548195-6C078E15-A3ED-402D-B916-CA7B9BC200AF Q35828340-DF2576AC-4960-47E5-AFC2-2FB4AC8416C4 Q36187060-FA02199E-19EB-4A1A-A77D-E9A72CC32D0E Q36332732-3B67D4F2-FCED-4A27-A29A-AB638E0EAFE4 Q36691642-D608DEFA-B0DC-4DD1-9FF6-BF00523D95FF Q37173329-D28984CE-6EA4-407C-8DA7-AB633CFE31C1 Q37330178-6DF20716-D8C5-45FB-BFD1-331F841308E0 Q37411350-B4F2B5A5-A060-47A0-8AD8-6965AC48FE0C Q37855900-886C5335-22F5-4DFA-9C0C-13FBA95D7C51 Q37951610-D796D573-27E9-4F58-A3C5-6BFE0557C780 Q38076139-32B71E34-C9B7-439D-9DF6-FC69383E6B53 Q38624961-09DB0722-ADAC-40AD-98C9-088DC6F22823 Q38861625-70203C00-66F5-482E-A7AF-36A47D4D8727 Q40074485-B4563DE9-F675-4B40-8B74-F30BC343DE76 Q40604377-659CD4F8-C064-47A0-91F4-C7A78612D8AA Q40985917-0E629E6A-5AE4-4847-AA87-B91A0CD6712B Q41015629-C6A871FE-6342-44C0-9628-0303B4932EAB Q42732016-7A61E284-0AB7-4FD7-8943-264A9EB9E449 Q46614586-0B69561D-1022-428E-A921-FB23307B77A9 Q47804153-7168D9BE-0A7E-4CBA-8E1B-B0261BE20BE4 Q49570576-1BD3951E-2AEA-4613-AA4C-9F6D709F1AAB Q50335864-F99B3F63-4331-4E66-9676-D9AE5EE15A80

P2860

Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells

http://www.wikidata.org/entity/Q28369657

description

1994 nî lūn-bûn

@nan

1994 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

1994 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

name

Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells

@ast

Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells

@en

Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells

@nl

type

label

Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells

@ast

Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells

@en

Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells

@nl

prefLabel

Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells

@ast

Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells

@en

Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells

@nl

P1433

Q28369657-0E1EDADD-725D-4B8B-A9EA-7108F44EBF5F

P1476

Q28369657-3E353BB1-566A-43F9-BDEC-E9AB82D61AB8

P2093

Q28369657-19EBBDE7-C285-4C47-A7E6-01C427334499

Q28369657-3B2877B2-EB36-45DB-8820-F897518BAA82

Q28369657-65E04ADD-AF23-4EE0-ACC8-DD2EDD6C8640

Q28369657-98C1179B-9771-4B56-8B0F-7A49488C7F06

Q28369657-A8FCB109-586F-4E25-BA68-9E59C4DFC976

Q28369657-B2A6F1A4-AA7F-4A8F-BD81-0674BA7A1B7B

Q28369657-BDBADD13-60AB-443B-95C9-99CDC66A089A

Q28369657-BEFE7F6C-448D-4223-BA66-3AEEB7A6564D

Q28369657-CD4B0D8E-6B7B-4589-B060-A0B05833A2D0

P2860

Q28369657-02B0993E-4F07-4FDE-9E4C-ADD742711936

Q28369657-0605E4D6-6D0B-457D-AE23-E91984DABA59

Q28369657-0657A083-5842-4EBB-AC7F-97231EFF14B6

Q28369657-2F026358-384C-4C3E-8E8B-113FC9C77D86

Q28369657-3087011C-5545-4E1B-B37E-272EFC27F0A7

Q28369657-336B7314-5952-48CA-9720-A7F785C78CF4

Q28369657-36C11D9C-E536-461A-B5C6-59D4C7CA96B4

Q28369657-4F201A45-571D-4543-9861-F57D29458F91

Q28369657-4F88FC92-AD6E-4C2A-81B5-5426237C43B0

Q28369657-61779829-B93E-4738-BD8C-90133FE1E0C3

P304

Q28369657-8588A790-63CC-4461-8962-B7C42F1AD273

P31

Q28369657-E2F84DD0-73C4-4B1B-B7DA-1A04F9055F1B

P356

Q28369657-A77D4C15-332A-43D2-8289-855C433671BB

P407

Q28369657-BD6FD46B-907A-4B8C-A020-CF85569B4357

P433

Q28369657-C6D18276-2637-47BF-B027-E8E73AC0DC7F

P478

Q28369657-6A3D6529-0B1B-400C-90D5-33231D59C68E

P50

Q28369657-4F14C517-0EDB-491D-ABC7-B28F990B28E0

P577

Q28369657-E70E33FD-F704-4BFB-9471-A9DFF4641549

P5875

Q28369657-6C2F214A-FAB9-481A-811C-794E90E4023F

P698

Q28369657-F1485E80-A0BE-419E-98AD-4499A6DAD0E9

P932

Q28369657-217EE38D-CAD1-4A7C-8873-79CA0FD89F9A

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells

@en

P2093

A Bousseau

http://www.w3.org/2001/XMLSchema#string

C Poujade

http://www.w3.org/2001/XMLSchema#string

F Soler

http://www.w3.org/2001/XMLSchema#string

J F Mayaux

http://www.w3.org/2001/XMLSchema#string

M Evers

http://www.w3.org/2001/XMLSchema#string

N Dereu

http://www.w3.org/2001/XMLSchema#string

R Pauwels

http://www.w3.org/2001/XMLSchema#string

T Huet

http://www.w3.org/2001/XMLSchema#string

Y Hénin

http://www.w3.org/2001/XMLSchema#string

P2860

A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition

Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event

An antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimidazo-[4,5,1-jk] [1,4]benzodiazepin-2 (1H)-one and -thione derivatives

Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds

A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication

Human immunodeficiency virus integration protein expressed in Escherichia coli possesses selective DNA cleaving activity

High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates.

Unpacking the incoming influenza virus.

Antiretroviral therapy: strategies beyond single-agent reverse transcriptase inhibition.

A rapid in vitro assay for HIV DNA integration.

P304

3564-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.91.9.3564

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P50

P577

1994-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15028209

http://www.w3.org/2001/XMLSchema#string

P698

8170948

http://www.w3.org/2001/XMLSchema#string

P932

43620

http://www.w3.org/2001/XMLSchema#string